Water → HCID 86703991, compound
Reaction equation
[CH3:1][C:2]1[N:11]2[C:5]([CH:6]([O:16][CH:17]3[CH2:22][CH2:21][N:20]([CH3:23])[CH2:19][CH2:18]3)[C:7]3[CH:15]=[CH:14][CH:13]=[CH:12][C:8]=3[CH2:9][CH2:10]2)=[N:4][C:3]=1[C:24]1[CH:38]=[CH:37][C:27]([C:28]([N:30]2[CH2:35][CH2:34][C:33](=[O:36])[CH2:32][CH2:31]2)=[O:29])=[CH:26][CH:25]=1.[BH4-].[Na+].O>CO>[OH:36][CH:33]1[CH2:34][CH2:35][N:30]([C:28]([C:27]2[CH:26]=[CH:25][C:24]([C:3]3[N:4]=[C:5]4[N:11]([CH2:10][CH2:9][C:8]5[CH:12]=[CH:13][CH:14]=[CH:15][C:7]=5[CH:6]4[O:16][CH:17]4[CH2:18][CH2:19][N:20]([CH3:23])[CH2:21][CH2:22]4)[C:2]=3[CH3:1])=[CH:38][CH:37]=2)=[O:29])[CH2:31][CH2:32]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 1-{4-[1-methyl-4-(1-methylpiperidin-4-yloxy)-9,10-dihydro-4H-3,10a-diaza-benzo[f]azulen-2-yl]-benzoyl}-piperidin-4-one (example 218) (93.7 mg, 0.183 mmole) in MeOH (2 mL) is added portionwise NaBH4 (10.5 mg, 0.275 mmole). After 2 hours at room temperature, water is added and the aqueous phase is extracted with AcOEt. AcOEt phase is dried over MgSO4, filtered and the solvent is removed under reduced pressure. The residue is purified by silica gel chromatography eluting with (CH2Cl2:MeOH) (90:1) then (CH2Cl2:MeOH:NH4OH) (9:1:0.1). The residual solid is triturated three times with Et2O to give (4-hydroxypiperidin-1-yl)-{4-[1-methyl-4-(1-methylpiperidin-4-yloxy)-9,10-dihydro-4H-3,10a-diaza-benzo[f]azulen-2-yl]-phenyl}-methanone.
Workup
- extractionthe aqueous phase is extracted with AcOEt
- dry with materialAcOEt phase is dried over MgSO4
- filtrationfiltered
- customthe solvent is removed under reduced pressure
- customThe residue is purified by silica gel chromatography
- washeluting with (CH2Cl2:MeOH) (90:1)
- customThe residual solid is triturated three times with Et2O
Sources & evidence
- ORD record
- ord-09957fe2759b4fc19d23bf57d8ffac0e
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09255101B2
Reaction notes
Loading…